Ron Kraus joined Syner-G in 2022 with 28 years of life science industry experience holding several executive leadership roles in both public and private equity-backed companies. Ron has broad global experience in the Bio/Pharma industry successfully serving in leadership roles as a Business Unit Head and Sales Executive. A common theme throughout his career is a passion for building expert teams and businesses providing unparalleled support in the development of life-saving therapies. What he says about the team at Syner-G: “Every day, I am inspired by the innovative work our teams conduct as we guide sponsors on the complex journey of bringing new therapies to deserving patients.”
The biopharmaceutical industry clearly isn’t going anywhere, but we’ve been in a downward business cycle. We've learned a lot from the pandemic and have adopted novel approaches to development and this current economic challenge will also inform us. In the meantime, adopting these strategies can de-risk your development programs.